Receptors for proteins modified by advanced glycation endproducts (AGE)—their functional role in atherosclerosis
Introduction
Modification of proteins by long-term incubation with glucose leads, through the formation of early stage products such as Schiff base and Amadori rearrangement products (Maillard, 1912), to the formation of advanced glycation end products (AGE). AGE-modified proteins are characterized physicochemically by fluorescence, brown coloration, and cross-linking, and biologically by specific recognition by the receptors for AGE-modified proteins (AGE-receptors). Three different AGE-receptors have so far been identified; the receptor complex of OST-48, 80K-H and galectin-3 (Li et al., 1996), the receptor for AGE (RAGE) (Neeper et al., 1992, Schmidt et al., 1992) and the macrophage scavenger receptor-A (MSR-A) (Araki et al., 1995, Suzuki et al., 1997). Since the invention of anti-AGE antibodies (Horiuchi et al., 1991, Nakayama et al., 1993), AGE-modified proteins have been demonstrated in several human tissues, implicating a potential link of AGE to aging processes and pathogenesis of diabetic microangiopathy (Vlassara et al., 1994) such as diabetic nephropathy (Makita et al., 1991, Skolnik et al., 1991, Makino et al., 1995), diabetic retinopathy (Yamagishi et al., 1997) and diabetic neuropathy (Yagihashi et al., 1992, Federoff et al., 1993), and other age-enhanced disease processes such as atherosclerosis (Nakamura et al., 1993, Kume et al., 1995), hemodialysis-related amyloidosis (Miyata et al., 1993) and actinic elastosis of photoxidized skins (Mizutari et al., 1997).
Among them, our immunohistochemical approaches using the monoclonal anti-AGE antibody (6D12) demonstrated that AGE-proteins are accumulated in macrophage-derived foam cells in the early stage and SMC-derived foam cells in the advanced stage in human atherosclerotic lesions (Kume et al., 1995). Many cellular experiments have clearly established that AGE-proteins are effectively endocytosed by macrophages or macrophage-derived cells (Vlassara et al., 1985). It was also known that MSR-A, the first receptor cloned among the scavenger receptor family, is preferentially expressed by macrophage-derived foam cells or intimal SMCs in the human atherosclerotic lesions. These data raised the possibility that AGE-proteins formed in situ are recognized by cellular components in atherosclerotic lesions through MSR-A, which may play some role in pathogenesis of atherosclerosis in arterial walls. In the present study, we have focused on the present status of how AGE-modification is potentially related to atherogenesis. In particular, we would like to emphasize the importance of MSR-A in the vascular dysfunction.
Section snippets
The presence of AGE-modified proteins in human atherosclerotic lesions
Our initial study using the monoclonal anti-AGE antibody demonstrated the localization of AGE-proteins in human atherosclerotic lesions in frozen sections of aortas of 25 autopsy cases (Kume et al., 1995). These lesions were divided into diffuse intimal thickening, fatty streak and atherosclerotic plaque; diffuse intimal thickening represents a flat intimal thickening caused by increased fibrous tissues, fatty streak is characterized by flat or slightly elevated lesions with local accumulation
AGE-receptors of macrophages
AGE-proteins are known to undergo the receptor-mediated endocytosis by macrophage and macrophage-derived cells in vitro. Vlassara et al. (1985) were the first to report a receptor-mediated endocytic uptake of AGE-proteins by murine peritoneal macrophages. Independent of this development, we have been interested in the phenomenon of rapid plasma clearance of intravenously injected formaldehyde-modified proteins in rats (Mego et al., 1967). Our results revealed that the rapid plasma clearance was
Future study
To understand the molecular mechanisms of AGE-induced pathogenesis of vasculature and neurons, structural and functional analyses of AGE-binding proteins or AGE-receptors are indispensable. As described in this text and references, many of the AGE-induced cellular responses are demonstrated to be mediated by the AGE-receptors. It is possible that more than two receptors are involved in AGE-induced cellular responses, such as endocytosis, growth-promoting effect and cytokine induction, while
Conclusion
Long-time interaction of AGE-proteins with the AGE-receptors might induce pathogenic effect on cells and tissues. At present, we can not answer which AGE-receptor is the most responsible for AGE-induced pathogenesis of vessels or neuronal cells. However, it seems reasonable to expect that the MSR-A expressed in macrophage-derived foam cells in the early stage of atherosclerotic lesions in arterial walls is involved in AGE-induced atherogenic processes. It does not, of course, rule out the
Acknowledgements
We are grateful to Drs Takayuki Higashi, Kazuyoshi Ikeda, Yoshiteru Jinnouchi, Norie Araki, Takashi Mori, Shuichi Kume, Kiyoshi Takahashi, Hiroshi Suzuki and Tatsuhiko Kodama for their collaborative endeavors. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan.
References (58)
- et al.
Cloning of novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages
Cell
(1995) - et al.
Scavenger function of sinusoidal liver cells: acetylated low-density lipoprotein is endocytosed via a route distinct from formaldehyde-treated serum albumin
J. Biol. Chem.
(1985) - et al.
Characterization of a membrane associated receptor from rat sinusoidal liver cells that binds formaldehyde-treated serum albumin
J. Biol. Chem.
(1985) - et al.
Scavenger receptor for aldehyde-modified proteins
J. Biol. Chem.
(1986) - et al.
Immunochemical approach to characterize advanced glycation end products of Maillard reaction; evidence for the presence of a common structure
J. Biol. Chem.
(1991) - et al.
Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy
Kidney Int.
(1995) - et al.
Photoenhanced modification of human skin elastin in actinic elastosis by Nε-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction
J. Invest. Dermatol.
(1997) - et al.
Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation
J. Biol. Chem.
(1993) - et al.
Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products
J. Biol. Chem.
(1998) - et al.
Advanced glycation end products driven angiogenesis in vivo. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factors
J. Biol. Chem.
(1997)
Expression cloning of SR-BI, a CD36-related Class B scavenger receptor
J. Biol. Chem.
Expression cloning of a novel scavenger receptor from human endothelial cells
J. Biol. Chem.
Macrophage scavenger receptor mediates the endocytic uptake of advanced glycation end-products of the Maillard reaction
Eur. J. Biochem.
Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells
J. Clin. Invest.
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues
Am. J. Pathol.
Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis
Annu. Rev. Biochem.
Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor
Proc. Natl. Acad. Sci. USA
CD36 is a receptor for oxidized low density lipoprotein
J. Biol. Chem.
Nonenzymatic glycosylation of laminin and the laminin peptide CIKVAVS inhibits neurite outgrowth
Diabetes
Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein
Proc. Natl. Acad. Sci. USA
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
Proc. Natl. Acad. Sci. USA
The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells
Diabetes
Purification of two distinct proteins of approximate Mr 80 000 from human epithelial cells and identification as proper substrates for protein kinase C
Biochem. J.
The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin
J. Biol. Chem.
Receptor-specific induction of insulin-like growth factor I (IGF-I) in human monocytes by advanced glycosylation endproduct-modified proteins
J. Clin. Invest.
Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils
Nature
Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta using a novel specific monoclonal antibody
Am. J. Pathol.
Molecular identity and cellullar distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins
Proc. Natl. Acad. Sci. USA
Oxidized or acetylated low density lipoproteins are rapidly cleared by the liver in mice with disruption of the scavenger receptor class A type I/II gene
J. Clin. Invest.
Cited by (59)
Diabetes, metabolic disease, and telomere length
2021, The Lancet Diabetes and EndocrinologyCitation Excerpt :Telomeres are sensitive to DNA damage because the 3' single-stranded telomeric overhangs with G-rich sequences are prone to single-stranded breaks, particularly in response to oxidative stress.3,4 Several studies show that shorter telomere length is a biomarker of oxidative stress,4 which can accelerate telomere shortening.5–7 In humans, telomere length is correlated with biomarkers of oxidative stress8,9 which are often increased in diabetes.
Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products
2011, Biochimica et Biophysica Acta - Molecular Basis of DiseaseCitation Excerpt :Recent studies show that oxidative stress and advanced glycation also play an important role in the development of diabetic macrovascular disease [5,6]. AGE contributes to the progression of atherosclerosis and accelerates oxidative stress by interacting with a specific receptor RAGE on vascular cells [7–10]. RAGE, a member of the immunoglobulin superfamily of cell surface molecules, is a multi-ligand receptor on vascular cells that plays a key role in inflammatory processes [11].
Dietary hyperglycemia, glycemic index and metabolic retinal diseases
2011, Progress in Retinal and Eye ResearchCitation Excerpt :The RAGE is a member of the immunoglobulin super-family with a high affinity for several ligands, including AGEs, high mobility group-1 protein, amyloid-β peptide, and S100B/calgranulins, some of which are known components of drusen and Bruch’s membrane deposits. On the other hand, despite of the protective role of AGE receptors it is thought that many of the adverse effects caused by AGEs are mediated via AGE receptors and that these receptors play a critical role in AGE-related pathobiology associated with diabetes and aging disorders (Sano et al., 1999; Schmidt et al., 2000; Vlassara, 2001). For example, activation of the RAGE evokes downstream proinflammatory responses that could play a critical role in aging (Yan et al., 2007), such as skin ageing (Lohwasser et al., 2006), and age-related diseases (Schmidt et al., 2000; Yan et al., 2007), such as Alzheimer’s disease (Takeuchi and Yamagishi, 2008), atherosclerosis (Ehlermann et al., 2006), dysfunction of cardiomyocytes (Gao et al., 2008), and retinal diseases (Stitt et al., 2005).
Prevention and treatment of diabetic nephropathy
2005, Diabetes Research and Clinical PracticeCollagen crosslinking: Effect on structure, mechanics and fibrosis progression
2021, Biomedical Materials (Bristol)